AI assistant
Edwards Lifesciences Corp — Director's Dealing 2012
May 11, 2012
30042_dirs_2012-05-11_95438332-3685-431a-8845-539cfb39182b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-05-09
Reporting Person: Wood Larry L (CVP, THV Replacement)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-09 | Employee Stock Option (Right to Acquire) | $85.4500 | A | 37800.0000 | Acquired | 2019-05-08 | Common Stock (37800.0000) | Direct |
| 2012-05-09 | Performance Rights | $ | A | 3650.0000 | Acquired | 2015-03-31 | Common Stock (3650.0000) | Direct |
Footnotes
F1: This option was granted on May 9, 2012 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and becomes exercisable commencing one year after the grant date in four equal annual installments.
F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
F3: Reflects the target number of shares (the Target Award) covered by unvested Restricted Stock Units granted on May 9, 2012. The number of shares issuable at vesting will depend upon achievement of the performance goals and will range from zero percent (0%) of the Target Award to one hundred seventy five percent (175%) of the Target Award.